Quad Technologies
www.rndsystems.comQuad Technologies, a Bio-Techne brand is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Our new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype. At Quad Technologies, we are committed to supporting researchers and clinicians working in the areas of translational medicine and cell therapy applications by delivering an industry-leading cell separation technology. Through our collaborative relationships with thought leaders in clinical, pharmaceutical and biological research arenas, our expert team is helping exceptional scientists accelerate development of disruptive cell processing technologies for CAR-T cancer therapies and stem cell based regenerative medicine. Quad Technologies is enabling life via scientific innovation.
Read moreQuad Technologies, a Bio-Techne brand is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Our new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype. At Quad Technologies, we are committed to supporting researchers and clinicians working in the areas of translational medicine and cell therapy applications by delivering an industry-leading cell separation technology. Through our collaborative relationships with thought leaders in clinical, pharmaceutical and biological research arenas, our expert team is helping exceptional scientists accelerate development of disruptive cell processing technologies for CAR-T cancer therapies and stem cell based regenerative medicine. Quad Technologies is enabling life via scientific innovation.
Read moreCountry
State
Massachusetts
City (Headquarters)
Woburn
Industry
Employees
11-50
Founded
2013
Estimated Revenue
$250,000,000 to $500,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Founder and Sales Head
Email ****** @****.comPhone (***) ****-****Senior Quality Control Analyst
Email ****** @****.comPhone (***) ****-****Automation Tester
Email ****** @****.comPhone (***) ****-****Junior Test Engineer
Email ****** @****.comPhone (***) ****-****
Technologies
(77)